(CRD-A) Crawford - Ratings and Ratios

Crawford & Company is a global leader in claims management and outsourcing solutions, serving insurance carriers, brokers, and corporations across multiple regions, including the United States, the United Kingdom, Europe, Canada, Australia, Asia, and Latin America. The companys comprehensive suite of services includes claims management, field investigation, and loss mitigation, as well as risk management information and consultative analytical services. With a presence in numerous markets, Crawford & Company is well-positioned to handle claims related to various types of insurance, including property, casualty, workers compensation, and more.

In addition to its core claims management services, Crawford & Company offers a range of specialized services, including managed repair and outsourced contractor management, staff augmentation, and subrogation claims management. The companys expertise in handling complex claims, including those resulting from natural disasters and man-made catastrophes, has earned it a reputation as a trusted partner in the insurance industry. With a history dating back to 1941, Crawford & Company has established itself as a stalwart in the industry, with a strong presence in the global market.

From a technical analysis perspective, Crawford & Companys stock (CRD-A) is currently trading at $10.59, with a 20-day SMA of $10.49 and a 50-day SMA of $10.62, indicating a relatively stable trend. The stocks ATR is 0.41, representing a 3.84% volatility. Given the current technical indicators and fundamental data, including a P/E ratio of 17.57 and a forward P/E of 10.75, we can forecast that the stock may experience a moderate increase in value over the next quarter, potentially reaching $11.50, driven by the companys solid financial performance and growth prospects.

Based on the fundamental data, Crawford & Companys market capitalization stands at $514.73M USD, with a return on equity (RoE) of 22.48%. The companys forward P/E ratio suggests that investors expect earnings growth in the coming year. By combining this information with the technical data, we can infer that the stock is likely to experience a gradual upward trend, potentially driven by the companys continued expansion into new markets and its strong position in the claims management industry. As such, a potential investment strategy could involve accumulating the stock at current levels, with a target price of $12.00 over the next 6-12 months.